By 2024, United States molecular diagnostics market is expected to cross US$ 9 billion. Main factors pouring the growth of molecular diagnostics market are increased incidence of infectious diseases and different types of cancer. On the other hand, advancement of new technologies in the field of medicine and research fuels the molecular diagnostics market.
A diagnosis based on symptoms and use of substitute markers is replaced by the genomic and the proteomic analysis. Molecular diagnostics system is one of the promising systems which can transform disease diagnosis. It offers the assurance for early disease detection, potentially before symptoms have even occurred.
Molecular oncology tests have emerged as a substantial market segment. Today in the field of medical diagnostics, molecular diagnostics for cancer testing offers one of the key areas for innovation and expansion. The United States leads the regional market for blood screening and blood products. Molecular diagnostics is also a significant tool for Food Pathogen Detection Testing and HLA Testing as well as other diseases.
United State Molecular Diagnostics Market Analysis
United States molecular diagnostics market has been classified into three main categories: Oncology Test, Infectious Disease Test and Genetic Disease Test. Oncology Test has been classified into four main categories: Breast Cancer Test, Colorectal Cancer Test, Prostate Cancer Test and Other Cancer Test. Infectious Disease Test has been classified into four main categories, namely, Virology, HAI, HPV and Critical Care Test and Genetic Test has been segmented into Blood Screening, HLA and Food Pathogen Test.
United State Molecular Diagnostics Market Shares: Overview
According to this report, In the United States Molecular Diagnostics Market, Infectious Test market and the Oncology Test both have a significant market. In Molecular Oncology Test market; Breast cancer is dominating the market while in Molecular Infectious test market; Virology leads all other segments. In the area of Tests Volume; Genetics test drives all way ahead from Infectious and Oncology Test owing to Food Pathogen Test Volume.
Key Players in the United State Molecular Diagnostics Market
This report describes the players and in- depth analysis of these players, the players who played a very vital role in the development of molecular diagnostics in the United State are Roche, Hologic, Becton Dickinson, Myraid Genetics, Qiagen, Abbott, Siemens, bioMérieux and Cepheid.
Renub Research study titled “United States Molecular Diagnostics Market, Test Volume Forecast & Companies: Oncology Test (Breast, Colorectal, Prostate) Infectious Diseases Test (Virology, HPV, HAI, Critical Care) Genetic Test (Blood Screening, Food Pathogen, Tissue Typing HLA)” provides a comprehensive assessment of the fast–evolving, high–growth United States Molecular Diagnostics Market. This is the 2nd edition of the report published by Renub Research.
This 146 page report with 87 Figures and 4 Tables studies the United States Molecular Diagnostics from 4 view points:
1) Molecular Diagnostics Market and Forecast 2) Segments Market & Forecast 3) Segments Test Volume & Forecast 4) Company Molecular Diagnostics Sales & Forecast
United States Molecular Diagnostics Market & Test Volume – Application Segment Analysis (2010 – 2024)
1. Oncology Test a) Breast Cancer b) Colorectal Cancer c) Prostate Cancer d) Others
2. Infectious Diseases a) Virology Test b) HPV Test c) HAI Test d) Critical Care Test
3. Genetic Test a) Blood Screening b) Food Pathogen Test c) Tissue Typing (HLA Test)
The HLA typing market is projected to grow at a CAGR of 5.9% during the forecast period. The global HLA typing market is projected to reach USD 1.7 billion by 2025 from USD 1.3 billion in 2020, at a CAGR of 5.9%. Growth in the HLA typing market is mainly driven by factors such as the increasing number of HLA typing procedures...
The electrophoresis market is projected to grow at a CAGR of 6.0% during the forecast period. The electrophoresis market is expected to reach USD 3.6 billion by 2025 from USD 2.7 billion in 2020, at a CAGR of 6.0% during the forecast period. The rising incidence of cancer, infectious diseases, and genetic disorders; growth...
Biochips are being increasingly used in the area of biomedical and biotechnological research. With the advancement of technology in the medical field, there has been a rise in adoption of biochips in proteomics, such as in microarrays. The advantages of protein biochips include low sample consumption and its inclination towards miniaturization....
The global HLA typing for transplants market is projected to grow at a CAGR of 6.7% during the forecast period. The global HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%. The demand for HLA typing products for transplant is expected to grow...
333 pages •
By Global Industry Analysts
• May 2020
Amid the COVID-19 crisis and the looming economic recession, the Next Generation Sequencers market worldwide will grow by a projected US$11.8 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 18.3%. Consumables, one of the segments analyzed and sized in this study, is forecast to grow at over...
276 pages •
By Global Industry Analysts
• May 2020
Amid the COVID-19 crisis and the looming economic recession, the qPCR and dPCR Instrumentation market worldwide will grow by a projected US$2.7 Billion, during the analysis period, driven by a revised compounded annual growth rate (CAGR) of 7.5%. qPCR, one of the segments analyzed and sized in this study, is forecast to grow at over 7.4%...
The global transplant diagnostics market is expected to grow at a CAGR of over 6% during the forecast period 2019–2025. The following factors are likely to contribute to the growth of the transplant diagnostics market during the forecast period: •Growing Number of Transplantations & Prevalence of Chronic Diseases •Increasing Shift...
The global sepsis diagnostics market is projected to grow at a CAGR of 8.5% during the forecast period. The global sepsis diagnostics market size is expected to reach USD 700 million by 2025 from USD 429 million in 2019, at a CAGR of 8.5%. The demand is expected to grow due to the rising incidence of sepsis, a growing number...
This 180-page report provides detailed analyses of current and emerging molecular diagnostic technologies, and their potential market applications, including DNA sequencing, RNA probes, detection technologies, biochips, genosensors, microarrays, labs-on-the-chip, and other.The report also presents strategic assessments of current...
The rising prevalence of infectious diseases and the introduction of newer pathogens, and the cost-benefits of INAAT is expected to drive the overall growth of the INAAT market The global isothermal nucleic acid amplification technology (INAAT) market size is expected to grow from USD 1.9 billion in 2019 to USD 3.3 billion by 2024, at a...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.